A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
Clinical trial NCT04658199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04658199
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2027-12-13
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.